TSS
CORT icon

Two Sigma Securities’s Corcept Therapeutics CORT Stock Holding History

Two Sigma Securities’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
+2,959
New +$179K 0.02% 994
2026
Q1 		– Sell
-7,572
Closed -$264K – 1732
2025
Q4 		$264K Buy
+7,572
New +$595K 0.04% 701
2025
Q3 		– Sell
-5,652
Closed -$415K – 1489
2025
Q2 		$415K Buy
+5,652
New +$410K 0.05% 505
2016
Q4 		– Sell
-34,339
Closed -$223K – 736
2016
Q3 		$223K Buy
+34,339
New +$200K 0.08% 395

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Securities's CORT Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 2,959 shares worth $257K. The stake represents 0.02% of the portfolio and ranks #994 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CORT as recently as Q4 2025.

Two Sigma Securities first reported a position in CORT in Q3 2016 and has held it in 4 quarters since. The position peaked at $415K in Q2 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Two Sigma Securities held 2,959 shares of Corcept Therapeutics worth $257K as of Q2 2026.
  • Corcept Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Corcept Therapeutics made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #994 holding.
  • Two Sigma Securities first reported a position in Corcept Therapeutics in Q3 2016 and has held it in 4 quarters since.
  • Two Sigma Securities's Corcept Therapeutics position peaked at $415K in Q2 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.